About 34 results
Open links in new tab
  1. OnCore - Login

    Support Links Chrome Firefox Safari Edge View Versions © 2026 Advarra, Inc.

  2. Huntsman Cancer Institute Clincial Trials

    Disease sites may be classified into broader categories. For example, colon, pancreas, and liver cancers are all classified under Gastrointestinal cancers; ovarian, uterine and endometrial cancers are …

  3. Huntsman Cancer Institute Clinical Trials

    SIP Version 14.0.0.010 Copyright © 2001-2020 Forte Research Systems, Inc. all rights reserved.

  4. Inclusion Criteria Age 18 years or older;At least one measurable lesion according to RECIST v1.1 OR evaluable disease for a limited number of patients (up to 10) in Group H;Performance status of …

  5. Objectives Primary Objective To assess the safety and tolerability of using hypoxia PET/CT imaging with Fluorine-18 fluoromisonidazole (FMISO) and MRI measures of radioresistance to personalize …

  6. Inclusion Criteria Inclusion Criteria: Patients who meet all the following criteria may be included in the study: Written informed consent and assent, according to local guidelines, signed and dated by the …

  7. To evaluate the safety and tolerability of BGB-11417 in combination with dexamethasone and dexamethasone plus carfilzomib in patients with relapsed/refractory (R/R) multiple myeloma (MM) …

  8. Objectives Primary Objectives Per Health Authority guidelines for gene therapy medicinal products that utilize integrating vectors (eg, retroviral vectors), long-term safety and efficacy follow up of treated …

  9. Objectives The overall objective of this research proposal is to provide a new treatment-assessment paradigm for MRgFUS breast cancer ablation therapy. Utilizing advanced in vivo MRI-to …

  10. Objectives Primary Objective(s) To evaluate recurrence-free survival (RFS) in participants with resected pancreatic neuroendocrine tumors (pNETs) randomized to treatment with capecitabine + …